Business Brief -- SPI Pharmaceuticals Inc.:
   Firm Says Its 1991 Sales
   Were About $360 Million
Milan Panic, chairman and chief executive officer, said in
a release that 1991 sales include eight months of sales of
the company's new Eastern European venture, ICN Galenika. He
said that SPI expected to report full financial results for
1991 in mid-March.